R factors determining multiple resistance including both gentamicin and carbenicillin have been identified in high incidence among hospital isolates of Pseudomonas aeruginosa. The factors are readily transmitted to other P. aeruginosa but not to Escherichia coli strains K-12 or C, or to Proteus mirabilis. R factor-containing isolates are predominantly immunotype 7 isolated from urinary sources.
Pseudomonas aeruginosa, although resistant to many antibiotics, has been generally susceptible to gentamicin and carbenicillin. Recently, descriptions have appeared of R factors in this organism, including reports of factors determining resistance to one or the other of these antibiotics (3, 4, 8, 9, 11, 12, 14, 15, 17) . These findings prompted our search for transmissible drug resistance among clinical strains of P. aeruginosa identified in the University of Cin--cinnati Medical Center. Strains resistant to gentamicin and/or carbenicillin were examined.
We have identified P. aeruginosa R factors with efficient transfer of enhanced resistance to gentamicin, carbenicillin, streptomycin, tetracycline, sulfonamides, chloramphenicol, and mercury ion. The predominant and prevalent source of strains bearing such factors has been from infections and colonizations of hospital patients with urinary tract complications (J. M. Slepack, unpublished data). The R factors are transferrable to other P. aeruginosa but not Escherichia coli or Proteus mirabilis. Clinical isolates with these factors are predominantly immunotype 7, even though this immunotype is rare among the R-isolates from this hospital. However, from representative data it appears that these factors do not alter the host immunotype. Aspects of this population of R factors appear in this report. Further biological and molecular properties of one of these factors are presented in a companion paper (10 donor and recipient were combined with complex medium in test tubes (18 by 150 mm) to yield 0.5-ml mating mixtures. These were incubated stationary for 4 h at 37 C; aliquots were then seeded upon tryptic soy agar selection plates. By the current procedure, exponential phase cells of each donor and recipient are combined to yield 2 ml of complex medium mating mixture in 4-oz (about 105 ml) prescription bottles. These are incubated on their flat surface at 37 C. After 2 h, the mixed cultures are transferred to tubes, vortexed vigorously for 1 min, diluted, and plated on appropriate selection plates. Donor and recipient are grown and plated separately as controls. These procedures are also followed for quantitation of mating frequencies. In such cases, 108 of each of the parental strains are mated. Frequencies of transcipients are expressed relative to the number of donor cells in mating mixtures at the end of incubation.
Routine transfer selections from clinical isolates as donors employed gentamicin or carbenicillin, with rifampin included in the plates for counter-selection of the donor. Transcipients were purified by singlecolony isolation on similar plates, repeated once. Ten such isolates from each selection were examined for growth on altemate selection plates to score the patterns of multiple resistance transfer.
Transfer from R-containing variants of PL1 and other auxotrophic strains utilized mutritional deficiency for counter-selection.
Immunotyping of P. aeruginosa strains was conducted by the methods, immune sera, and immunotype control strains provided by Parke-Davis (7) .
RESULTS
During December 1973 and January 1974, one or more isolates of P. aeruginosa was recorded from each of 87 patients in the local Veterans Administration hospital. For 23 of these patients, the cultures included strains clinically resistant to both gentamicin and carbenicillin as determined by the Bauer-Kirby method (2). The sources of P. aeruginosa of the various gentamicin and carbenicillin resistance patterns are broadly indicated in Table 2 . In the majority of cases, the organism was obtained from cultures of the urine, urinary tract, or from urinary catheters. Virtually all of the multiply resistant organisms were isolated from patients with urinary infections or colonizations (21 of the 23 patients).
Of the 23 patients, multiply resistant isolates from 20 were available for our examination. One isolate from each of the 20 was surveyed for transfer, to PL1, of resistance to gentamicin, carbenicillin, streptomycin, or tetracycline in single antibiotic selection platings. For 14 of the 20, transfer of resistance to each of the four antibiotics was observed, with each transcipient showing complete co-transfer of the resistance pattern.
Such isolates were examined further with respect to the presence and transmissibility of additional resistance traits. The ojverall pattern obtained is typified by the data in Table 3 . Strain PL10 is a sputum sample isolate, chosen at random as a representative antibiotic-sensitive strain. Strain PL11, and its resident factor RPL11, typify the major resistant transfer population. Strain PL34 is included as a clinical isolate of a gentamicin-sensitive, carbenicillinresistant pattern. RPL11 transfers resistance, on November 2, 2017 by guest http://aac.asm.org/ Downloaded from (clinically significant by the Bauer-Kirby method), to gentamicin, carbenicillin, streptomycin, tetracycline, and sulfonamides (Table  3 , lines 1 to 5). Also transferred are enhanced resistance to chloramphenicol and to HgCl2. Sensitivities to kanamycin and to tobramycin are unaffected by presence of the R factor (Table 3 ). All strains are sensitive to colistin (data not shown).
Influences of alternate hosts upon gentamicin resistance are shown in Table 3 (lines 6 to 10). Comparable effects are seen with the experimentally derived PL1 (RPL11) and PL1 Table 3 with the exception of sensitivity to chloramphenicol and HgCl2, which were omitted. Thirty R factors were examined including one or more from each of the 14 patients. Twenty-seven of these 30 showed a pattern common to RPL11 (Table 3 , line 7). The remaining three had the resistance properties of RPL44 (Table 3 , line 11). Secondarily, eight of these 27, in addition to RPL11, were examined, and all eight were shown to' confer chloramphenicol and mercury resistance.
Factor RPL11 has been quite stable, both in PL1l and in various transcipients. This is true both in terms of maintenance of transferability of R factor through overnight culture in complex medium without antibiotics, and in terms of retention of the entire antibiotic resistance pattern. Host range and frequency of transfer. Initially, mating surveys were conducted with subcultures from overnight, stationary cultures with mating periods of from 2 h to overnight. It was later determined that the use of log phase cells as described above gave approximately a 10-fold increase in efficiency of transfer. Essentially 100% transfer can be obtained under these conditions when strain 280 of Bryan or its derivatives are used as recipient. By contrast, transfer frequencies with PU21 as recipient are on the order of 10-9. None of the several R factors tested was observed to transfer to E. coli K12 (PL353), to E. coli C (PL358), or to Proteus mirabilis PM17. In these tests, donor cell titers were determined only for representative matings with PL11, revealing no transfer at the level of 10-' (10).
Clinical R+ isolates are predominately immunotype 7. To examine the relationship of R factor and host immunotype, we characterized strains by the Parke-Davis system of immunotypes 1 through 7 (7). As presented in Table 4 , the majority of the clinical R+ isolates are type 7. This is true even though this immunotype is rare among the R-isolates. However, based upon studies involving RPL11 in a variety of strains of distinct immunotype, these R factors do not confer immunotype specificity (10) . DISCUSSION Generally, isolation of P. aeruginosa resistant to both gentamicin and carbenicillin has occurred only rarely among hospital populations (5). It is clear that in the Cincinnati Veterans Administration Hospital, a high incidence of these organisms is related to the dissemination of an R factor bearing these traits. The R factors recognized here form a highly homogenous population. This is apparent in their overall resistance pattern, which for 27 of 30 isolates examined includes resistance at clinically significant levels to streptomycin, tetracycline, and sulfon- amide as well as to gentamicin and carbenicillin. Other properties apparently common to these factors are determinants for enhanced resistance to mercury ion and to chloramphenicol (nine of nine examined). In addition to the majority of isolates with this resistance pattern, we have isolated others with a basic pattern of carbenicillin, streptomycin, and sulfa resistance transfer. Comparable subpatterns have developed through the subculture of some isolates in the laboratory. We thus suspect that the great majority of the P. aeruginosa in this hospital owe their gentamicin and/or carbenicillin resistance to this "family" of R factors. These factors are highly fertile with respect to P. aeruginosa strains, and their host range appears to be restricted to Pseudomonas.. It is clear that the resistance pattern correlates with P. aeruginosa from urinary tract sources (Table 2) (6) . A possible complication is that the presence of an R factor may change typing characteristics of the host. Jacoby has reported an inhibition of propagation of som3 phage, and an inhibition of production of standard pyocins, by R factor pMGl in P. aeruginosa PU21 (9) . The relationships of the R factors described here to the expression of host bacteriophage and pyocin typing remain to be examined. However, as detailed in the accompanying paper, RPL11 can be transferred in the laboratory to a variety of P. aeruginosa without influencing their immunotype. In this hospital population, immunotype 7 is predominant among R-bearing strains whereas type 7 Rstrains have been seen but rarely (Table 4) . One patient who was colonized with a type 7 R+ organism when released from the hospital was shown upon return four weeks later to be carrying apparently the same R factor but in a type 3 organism. Thus, it appears that these R factors can transfer to different P. aeruginosa without altering the host immunotype. A particular host strain, in this case immunotype 7, having acquired an R factor, was then successful in widespread nosocomial colonization. This model is being tested in further epidemiologic studies. The high incidence of R factors determining resistance to both gentamicin and carbenicillin in this hospital suggests that such R factors may become a general problem. Since these are the antibiotics of choice for treatment of pseudomonas infections, it is encouraging that these R factors do not appear to influence antigenic specificity, at least as regards the 7 major immunotypes. It may be hoped that immunotherapy (1) will provide an effective treatment for patients infected with P. aeruginosa carrying antibiotic resistance factors.
